胸腺嘧啶负荷试验预测氟嘧啶类相关严重胃肠毒性
本病例对照研究评估尿胸腺嘧啶负荷试验是否能区分接受5-氟尿嘧啶或卡培他滨治疗患者中发生严重(≥3级)胃肠毒性者。37例患者口服250 mg胸腺嘧啶后收集0-4小时尿,检测胸腺嘧啶与二氢胸腺嘧啶比值。但结合肌酐清除率后 logistic 回归可区分多数病例(ROC曲线下面积0.8792,95%CI 0.72-1.00)。
要点
- 胸腺嘧啶负荷试验联合肾功能可能有助于识别高危患者。
核心结论
- 胸腺嘧啶负荷试验联合患者肾功能可能作为表型诊断试验,用于检测危及生命的氟嘧啶类胃肠毒性风险。
研究设计与样本
- 病例对照研究,纳入37例接受5-氟尿嘧啶或卡培他滨治疗的患者,口服250 mg胸腺嘧啶后收集0-4小时尿样。
- 病例组9例严重(≥3级)胃肠毒性,非病例组23例,毒性分级依据常见不良事件评价标准。
- 采用液相色谱/质谱法测定尿胸腺嘧啶及二氢胸腺嘧啶,分析DPYD基因变异,并根据血肌酐估算肾功能。
主要发现
- 联合胸腺嘧啶/二氢胸腺嘧啶比值与肾功能的logistic回归可区分多数病例,ROC曲线下面积0.8792(95%CI 0.72-1.00)。
临床怎么用
- 对于接受5-氟尿嘧啶或卡培他滨治疗的患者,可考虑胸腺嘧啶负荷试验联合肾功能评估来识别严重胃肠毒性高危者。
- 该试验尚属研究阶段,临床决策仍需结合DPYD基因检测等常规评估。
局限性
- 样本量较小(病例9例,非病例23例),结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: A previous study suggested that a thymine (THY) challenge dose could detect aberrant pharmacokinetics in known cases of fluoropyrimidine toxicity compared with healthy volunteers. The preliminary data suggested that urine sampling also could detect this aberrant disposition. The aim of this case-control study was to assess the ability of the urinary THY challenge test to discriminate cases of severe gastrointestinal toxicity in a cohort of patients treated with 5-fluorouracil or capecitabine. METHODS: Patients (n = 37) received a 250 mg (per os) dose of THY and a cumulative urine sample was collected for 0-4 h. The urinary amounts of THY and metabolite dihydrothymine (DHT) were determined by liquid chromatography/mass spectrometry. Genomic DNA was analysed for DPYD gene variants. Renal function was estimated from blood creatinine levels. Cases (n = 9) and noncases (n = 23) of severe (grade ≥ 3) gastrointestinal toxicity were defined based on Common Terminology Criteria for Adverse Events. RESULTS: The median THY/DHT ratios were 6.2 (interquartile range 2.9-6.4) in cases, including the 2 patients who were DPYD heterozygous carriers. However, this was not significantly different (P = .07) from the THY/DHT in noncases (median 2.6, interquartile range 2.8-4.2). Although creatinine clearance was lower (P = .001) in cases, renal function could not discriminate cases from noncases. However, logistic regression analysis using both of these explanatory variables could discriminate most cases (receiver operating characteristic area 0.8792, 95% confidence interval 0.72-1.00). CONCLUSIONS: The THY challenge test combined with a patient's renal function may be useful as a phenotypic diagnostic test to detect risk of life-threatening fluoropyrimidine gastrointestinal toxicity.
引用
- Helsby NA, Duley J, Burns KE, et al. A case-control study to assess the ability of the thymine challenge test to predict patients with severe to life threatening fluoropyrimidine-induced gastrointestinal toxicity. Br J Clin Pharmacol. 2019. PMID: 31658382. doi:10.1111/bcp.14153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。